Leisure Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-37,656
Closed -$359K 122
2019
Q1
$359K Sell
37,656
-127
-0.3% -$1.3K 0.3% 104
2018
Q4
$434K Sell
37,783
-1,627
-4% -$20.2K 0.41% 95
2018
Q3
$668K Sell
39,410
-4,266
-10% -$64.8K 0.54% 61
2018
Q2
$620K Buy
43,676
+3,714
+9% +$61.7K 0.53% 66
2018
Q1
$759K Sell
39,962
-753
-2% -$16.1K 0.67% 45
2017
Q4
$668K Buy
40,715
+865
+2% +$12.9K 0.55% 54
2017
Q3
$598K Sell
39,850
-691
-2% -$7.64K 0.52% 57
2017
Q2
$357K Sell
40,541
-1,317
-3% -$8.45K 0.32% 68
2017
Q1
$218K Sell
41,858
-1,150
-3% -$4.61K 0.19% 81
2016
Q4
$131K Buy
43,008
+809
+2% +$2.95K 0.12% 99
2016
Q3
$195K Sell
42,199
-253
-0.6% -$1.29K 0.18% 92
2016
Q2
$246K Buy
42,452
+55
+0.1% +$351 0.24% 79
2016
Q1
$257K Sell
42,397
-1,791
-4% -$10.8K 0.26% 74
2015
Q4
$403K Buy
44,188
+1,696
+4% +$13.1K 0.37% 67
2015
Q3
$240K Buy
42,492
+19,717
+87% +$163K 0.26% 74
2015
Q2
$253K Buy
22,775
+2,374
+12% +$30.6K 0.25% 71
2015
Q1
$320K Buy
20,401
+1,333
+7% +$20.6K 0.31% 67
2014
Q4
$290K Buy
+19,068
New +$232K 0.28% 66

Other funds holding SGMO

Leisure Capital Management's SGMO Position: Q2 2019 in Review

Leisure Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2019, closing a stake of 37,656 shares — an estimated $359K sold.

Leisure Capital Management first reported a position in SGMO in Q4 2014 and held it in 18 quarters. The position peaked at $759K in Q1 2018. 185 funds tracked by Wall St. Rank hold SGMO as of Q2 2019.

  • Leisure Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2019 after selling out during the quarter.
  • Leisure Capital Management sold 37,656 SANGAMO THERAPEUTICS INC shares in Q2 2019, an estimated $359K.
  • Leisure Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2014 and held it in 18 quarters.
  • Leisure Capital Management's SANGAMO THERAPEUTICS INC position peaked at $759K in Q1 2018.
  • 185 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2019.

Based on Leisure Capital Management's 13F filing for Q2 2019, filed 10 Jul 2019.